Fresenius Medical Care (NYSE:FMS) Earns Strong-Buy Rating from Analysts at StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of Fresenius Medical Care (NYSE:FMS – Get Free Report) in a research note issued to investors on Saturday. The brokerage set a “strong-buy” rating on the stock. Separately, Truist Financial upped their price target on shares of Fresenius Medical Care from $21.00 to $24.00 and gave the […]

Leave a Reply

Your email address will not be published.

Previous post Inter Parfums (NASDAQ:IPAR) Downgraded by StockNews.com to “Sell”
Next post Prospect Capital (NASDAQ:PSEC) Downgraded by StockNews.com